| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/17/2003 | US20030072812 Administering at a tumor site in a mammalian subject a pharmaceutically acceptable form of at least one iron compound or complex in a suitable carrier for therapy of breast cancer |
| 04/17/2003 | US20030072775 For immunization; for therapy of disseminated candidiasis |
| 04/17/2003 | US20030072769 Used in the manufacture of vaccines, therapy, prophylaxis, drug screening |
| 04/17/2003 | US20030072767 Compositions and methods for WT1 specific immunotherapy |
| 04/17/2003 | US20030072766 Comprising antiserum raised against a flagellaless Campylobacter strain for prophylaxis of Campylobacter colonisation in animals |
| 04/17/2003 | US20030072765 For therapy and prophylaxis of bacterial infections |
| 04/17/2003 | US20030072760 Anti-estrogen and immune modulator combinations for treating breast cancer |
| 04/17/2003 | US20030072759 Administering to a patient afflicted with a gastrointestinal tumor, a murine monoclonal antibody which specifically binds to an epitope of 17-1A antigen, the antibody being administered parenterally in multiple doses |
| 04/17/2003 | US20030072755 Administering antibody to a protein component or to a carbohydrate-protein component of P-selectin glycoprotein ligand for therapy of rheumatoid arthritis |
| 04/17/2003 | US20030072754 CD154 blockade therapy for pancreatic islet tissue transplantation |
| 04/17/2003 | US20030072753 Virus-like particles for the induction of autoantibodies |
| 04/17/2003 | US20030072752 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/17/2003 | US20030072751 Idiotypic vaccination against b cell lymphoma |
| 04/17/2003 | US20030072745 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030072742 Enhancement of immune response using targeting molecules |
| 04/17/2003 | US20030072736 Human tumor necrosis factor receptor TR16 |
| 04/17/2003 | US20030071835 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030071834 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | CA2462900A1 Reagents and methods useful for detecting diseases of the breast |
| 04/17/2003 | CA2462883A1 Use of bispecific antibodies to regulate immune responses |
| 04/17/2003 | CA2462873A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | CA2462687A1 Novel class ii cytokine receptor |
| 04/17/2003 | CA2461824A1 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 04/17/2003 | CA2461655A1 Nogo receptor-mediated blockade of axonal growth |
| 04/17/2003 | CA2461435A1 Angiopoietin-2 specific binding agents |
| 04/17/2003 | CA2461343A1 Mammalian c-type lectins |
| 04/17/2003 | CA2460625A1 Structural and cytoskeleton-associated proteins |
| 04/17/2003 | CA2460480A1 Molecules for disease detection and treatment |
| 04/17/2003 | CA2460476A1 Protein modification and maintenance molecules |
| 04/17/2003 | CA2458645A1 Intracellular signaling molecules |
| 04/17/2003 | CA2458464A1 Monoclonal and cdr-grafted antibodies specific for human kdr |
| 04/17/2003 | CA2458392A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 04/17/2003 | CA2426384A1 Antibody inhibiting vplf activity |
| 04/16/2003 | EP1302541A1 Receptor protein specifically recognizing bacterial dna |
| 04/16/2003 | EP1302533A1 Novel method of inducing the differentiation of embryonic stem cells into ectodermal cells and use thereof |
| 04/16/2003 | EP1302477A1 Peptide fructose and complex thereof with binding protein |
| 04/16/2003 | EP1301795A2 Method of identifying and/or isolating stem cells |
| 04/16/2003 | EP1301631A1 Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins |
| 04/16/2003 | EP1301605A2 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 04/16/2003 | EP1301602A2 Fh-binding protein of streptococcus pneumoniae |
| 04/16/2003 | EP1301599A2 Olfactory g-protein coupled receptor |
| 04/16/2003 | EP1301598A2 Cell cycle proteins and mitosis-associated molecules |
| 04/16/2003 | EP1301595A2 G-protein coupled receptors |
| 04/16/2003 | EP1301541A2 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| 04/16/2003 | EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 04/16/2003 | EP1301538A2 Artificial antibody polypeptides |
| 04/16/2003 | EP1301535A2 G-protein coupled receptors |
| 04/16/2003 | EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies |
| 04/16/2003 | EP1301206A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 04/16/2003 | EP1054691B1 Anti-enzyme antibodies for the treatment of the skin |
| 04/16/2003 | EP1041997B1 Use of citrulline peptides derived from filaggrin for treating autoimmune diseases |
| 04/16/2003 | EP0991667B1 Igg1 antibodies reactive to the surface of cryptosporidium oocysts |
| 04/16/2003 | EP0868522B1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 04/16/2003 | EP0769958B1 Inhibitors of leukocyte adhesion |
| 04/16/2003 | EP0750508B1 RETROPEPTIDES, ANTIBODIES THERETO, AND USES THEREOF FOR VACCINATION AND $i(IN VITRO) DIAGNOSIS |
| 04/16/2003 | EP0749443B1 Fk-506 cytosolic binding protein |
| 04/16/2003 | EP0667896B1 Direct selection of cells by secretion product |
| 04/16/2003 | EP0648127B1 Type i surface antigens associated with staphylococcus epidermidis |
| 04/16/2003 | EP0642356B1 Antibodies to p-selectin and their uses |
| 04/16/2003 | EP0605442B1 Recombinant antibodies for human therapy |
| 04/16/2003 | CN1411513A Method for detecting replication competent viruses in sera of subjects receiving gene |
| 04/16/2003 | CN1411378A Method for production of egg containing anti-pathogenic bacteria specific antibodies (IgY) and yogurt and ice cream containing IgY |
| 04/16/2003 | CN1410449A Identification and function research of gene p28-II |
| 04/16/2003 | CN1105728C Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders |
| 04/16/2003 | CN1105725C Modulators for functions of FAS/APO1 receptors |
| 04/15/2003 | US6548655 Interleukin-4 receptors |
| 04/15/2003 | US6548645 Immunoassay for 2-oxo-3-hydroxy LSD |
| 04/15/2003 | US6548641 PTP 1D: a novel protein tyrosine phosphatase |
| 04/15/2003 | US6548640 Complementarity determining regions in a light or heavy chain variable domains of the antibody have been replaced by analogs |
| 04/15/2003 | US6548636 Composition for use as viricide in prevention of viral infection |
| 04/15/2003 | US6548475 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury |
| 04/15/2003 | US6548306 Placental protein 13 |
| 04/15/2003 | US6548295 Complex of lipo-viro-particles, method of preparation and applications |
| 04/15/2003 | US6548284 Membrane-bound metalloprotease and soluble secreted form thereof |
| 04/15/2003 | US6548281 Polypeptides, polynucleotides formed via recombination; for screening for antibacterial compounds |
| 04/15/2003 | US6548270 An expression vector comprising a recombinant polynucleotide encoding a protein containing specific amino acid sequence; genetic engineering |
| 04/15/2003 | US6548067 Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof |
| 04/15/2003 | US6548066 Inducing antibodies; antitumor agent |
| 04/15/2003 | US6548062 Preferred for the treatment of prostate or pancreatic cancer. |
| 04/15/2003 | CA2117378C Htlv-i/htlv-ii assay and method |
| 04/15/2003 | CA2059979C Complex containing coagulation factor ix |
| 04/15/2003 | CA2034504C Fungal stress proteins |
| 04/10/2003 | WO2003029465A1 HepNaDC GENE |
| 04/10/2003 | WO2003029464A2 Genes associated with mast cell activation |
| 04/10/2003 | WO2003029458A2 Method for producing protein libraries and for selecting proteins from said libraries |
| 04/10/2003 | WO2003029451A2 Histone deacetylase 9 |
| 04/10/2003 | WO2003029437A2 Secreted proteins |
| 04/10/2003 | WO2003029436A2 Ul16 binding protein 4 |
| 04/10/2003 | WO2003029427A2 Human glandular kallikrein (hk2)-specific monoclonal antibodies that enhance or inhibit the enzymatic activity of hk2 |
| 04/10/2003 | WO2003029426A2 Human and murine cytokine polypeptides |
| 04/10/2003 | WO2003029424A2 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | WO2003029423A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/10/2003 | WO2003029419A2 Three dimensional structure of crystalline grp94 binding domain, and its methods of use |
| 04/10/2003 | WO2003029413A2 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | WO2003029407A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/10/2003 | WO2003029296A1 Human anti-cd40 antibodies |
| 04/10/2003 | WO2003029295A1 Human tissue factor antibodies |
| 04/10/2003 | WO2003029282A2 Tumor-peptide antigens from the human prdi-bf1-protein |
| 04/10/2003 | WO2003029262A2 The human mob-5 (il-24) receptors and uses thereof |
| 04/10/2003 | WO2003028840A2 Combined compositions and methods for tumor vasculature coagulation and treatment |